IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia
Authors:
Open Access
- 8 May 2011
- journal article
- research article
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 2 (2) , 105-109
Abstract
Background A hallmark symptom of cancer cachexia is the loss of skeletal muscle. This is at least partially due to a deregulation of the growth hormone/IGF-1 axis and a subsequently impaired protein...Keywords
This publication has 22 references indexed in Scilit:
- Brown fat biology and thermogenesisFrontiers in Bioscience-Landmark, 2011
- Cancer‐related fatigue: the impact of skeletal muscle mass and strength in patients with advanced cancerJournal of Cachexia, Sarcopenia and Muscle, 2010
- Cachexia as a major underestimated and unmet medical need: facts and numbersJournal of Cachexia, Sarcopenia and Muscle, 2010
- Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged SurvivalCell, 2010
- Update on clinical trials of growth factors and anabolic steroids in cachexia and wastingThe American Journal of Clinical Nutrition, 2010
- The influence of age and sex on disease development in a novel animal model of cardiac cachexiaInternational Journal of Cardiology, 2009
- Patient Selection for IGF-I TherapyHormone Research, 2006
- Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathwaysNature Cell Biology, 2001
- Effects of insulin‐like growth factor I treatment on statural growth, body composition and phenotype of children with growth hormone insentivity syndromeActa Paediatrica, 1999
- Effects of interactions between IGFBPs and IGFs on the plasma clearance and in vivo biological activities of IGFs and IGF analogs.1993